Abstract
Elevated serum brain natriuretic peptide (BNP) released from myocytes of ventricles upon stretch have been found in patients with isolated right ventricular (RV) pressure overload. However, limited data suggest that serum BNP may be elevated in systemic sclerosis (SSc) patients, especially with RV dysfunction. We assessed serum N-terminal proBNP (NT-proBNP) in SSc and evaluated whether it reflects the severity of RV overload. We prospectively studied 51 consecutive patients (47F, mean age 53.3 ± 15.2 years) with SSc (mean disease duration 9 ± 12.4 years). The control group formed 31 healthy subjects (27F, mean age 52.6 ± 12.1 years). NT-proBNP level, 6-minute walking test (6MWT), and transthoracic echocardiography (TTE) for the assessment of RV overload were performed. Serum NT-proBNP exceeded the reference value of 125 pg/mL in 31 (61%) SSc patients. The mean serum log NT-proBNP concentration in SSc was higher than in controls (2.138 ± 0.527 vs. 1.634 ± 0.420 pg/mL, p < 0.001). 13 (25%) SSc patients have tricuspid regurgitation peak gradient (TRPG) exceeding 31 mmHg reflecting pulmonary arterial hypertension (PAH). The SSc presented other echocardiographic signs of RV overload. Mean 6MWT distance was shorter in SSc than in controls (528 ± 100 vs. 617 ± 80 m, p < 0.001). NT-proBNP level correlated positively with TRPG, RV diameter, RV Tei index and negatively with 6MWT distance. ROC analysis identified >115 pg/ml as the best NT-proBNP threshold predicting PAH for SSc patients (sensitivity 92%, specificity 44%). Results of our study suggest that NT-proBNP measurement is a useful screening method for PAH in SSc patients. Since elevated plasma NT-proBNP level reflects the degree of right ventricular overload and limitation of exercise capacity, abnormal NT-proBNP levels should imply further evaluation including echocardiography.
Similar content being viewed by others
Abbreviations
- AcT:
-
right ventricular acceleration time
- BNP:
-
brain natriuretic peptide
- DLCO:
-
diffusion capacity of the lung for carbon monoxide
- EF:
-
left ventricular ejection fraction
- FEV1 :
-
forced expiratory volume in 1 s
- FVC:
-
forced vital capacity
- HR:
-
heart rate
- IVC:
-
diameter of inferior vena cava
- LV:
-
left ventricle
- NT-proBNP:
-
N-terminal proBNP
- PAH:
-
pulmonary arterial hypertension
- RV:
-
right ventricle
- SSc:
-
systemic sclerosis
- TLC:
-
total lung capacity
- TRPG:
-
tricuspid regurgitation peak gradient
- TTE:
-
transthoracic echocardiography
- 6MWT:
-
6-minute walking test
- Δ sat:
-
resting oxygen saturation − oxygen saturation after 6MWT
References
Wigley FM (1998) Clinical features of systemic sclerosis. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, NY, pp 1–14
LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma: classification, subset and pathogenesis. J Rheumatol 15:202–205
Koh E, Lee P, Gladman DD (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35:989–993
Schachna L, Wigley FM, Chang B et al (2003) Age and risk of pulmonary arterial hypertension in scleroderma. Chest 124:2098–2104
Morelli S, De Marzio P, Valesini G et al (1993) Pulmonary hypertension in systemic sclerosis. G Ital Cardiol 23:871–876
Hachulla E, Gressin V, Guillevin L et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis. Arthritis Rheum 52:3792–3800
Galie N, Manes A, Farahani KV et al (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14:713–717
Nagaya N, Ando M, Oya H et al (2002) Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy. Ann Thorac Surg 74:180–184
Nagaya N, Nishikimi T, Uematsu M et al (2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102:865–870
Mukerjee D, Yap L, Holmes AM et al (2003) Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respir Med 97:1230–1236
Emdin M, Marini C, Passino C (2004) Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis. Eur Heart J 6(suppl F):68–73
Williams MH, Handler CE, Akram R et al (2006) Role of N-terminal brain natriuretic peptide (NT-proBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 27:1485–1494
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Torbicki A, Kurzyna M, Ciurzyński M et al (1999) Proximal pulmonary emboli modify right ventricular ejection pattern. Eur Respir J 13:616–621
Galie N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur Heart J 25:2243–2278
Tei C, Dujardin KS, Hodge DO et al (1996) Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 9:838–847
Denton CP, Cailes JB, Phillips, GD et al (1997) Comparison of Doppler echocardiography and right heart catheterization in systemic sclerosis. Br J Rheumatol 36:239–243
Mukerjee D, St George D, Knight C et al (2004) Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 43:461–466
McGoon M, Gutterman D, Steen V et al (2004) Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126:145–345
Pruszczyk P, Kostrubiec M, Bochowicz A et al (2003) N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Resp J 22:649–653
Murata I, Takenaka K, Shinohara S (1998) Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients. Am Heart J 135:960–969
Jacobsen S, Ullman S, Shen GQ et al (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459
Steen V, Medsger TA Jr (2003) Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48:516–522
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was partially supported by grant KBN N402 085034.
Rights and permissions
About this article
Cite this article
Ciurzyński, M., Bienias, P., Lichodziejewska, B. et al. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis. Clin Rheumatol 27, 991–997 (2008). https://doi.org/10.1007/s10067-008-0837-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-0837-9